nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosiglitazone—ALB—Estropipate—osteoporosis	0.0878	0.128	CbGbCtD
Rosiglitazone—SLCO1B1—Conjugated Estrogens—osteoporosis	0.0758	0.111	CbGbCtD
Rosiglitazone—SLCO1B1—Estradiol—osteoporosis	0.0666	0.0973	CbGbCtD
Rosiglitazone—CYP1A2—Estropipate—osteoporosis	0.0525	0.0767	CbGbCtD
Rosiglitazone—CYP2C9—Estropipate—osteoporosis	0.0473	0.0691	CbGbCtD
Rosiglitazone—CYP2C8—Raloxifene—osteoporosis	0.0453	0.0661	CbGbCtD
Rosiglitazone—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0437	0.0639	CbGbCtD
Rosiglitazone—ALB—Estradiol—osteoporosis	0.0365	0.0533	CbGbCtD
Rosiglitazone—CYP2C8—Cholecalciferol—osteoporosis	0.035	0.0511	CbGbCtD
Rosiglitazone—CYP2C19—Cholecalciferol—osteoporosis	0.0293	0.0428	CbGbCtD
Rosiglitazone—CYP2C8—Estradiol—osteoporosis	0.0282	0.0412	CbGbCtD
Rosiglitazone—CYP1A2—Conjugated Estrogens—osteoporosis	0.0248	0.0363	CbGbCtD
Rosiglitazone—CYP2C9—Cholecalciferol—osteoporosis	0.0244	0.0356	CbGbCtD
Rosiglitazone—CYP2C19—Estradiol—osteoporosis	0.0236	0.0345	CbGbCtD
Rosiglitazone—CYP2D6—Cholecalciferol—osteoporosis	0.0223	0.0326	CbGbCtD
Rosiglitazone—CYP1A2—Estradiol—osteoporosis	0.0218	0.0319	CbGbCtD
Rosiglitazone—CYP2C9—Estradiol—osteoporosis	0.0197	0.0287	CbGbCtD
Rosiglitazone—Hypertension—Ibandronate—osteoporosis	0.000578	0.00267	CcSEcCtD
Rosiglitazone—Myalgia—Raloxifene—osteoporosis	0.000576	0.00266	CcSEcCtD
Rosiglitazone—Arthralgia—Raloxifene—osteoporosis	0.000576	0.00266	CcSEcCtD
Rosiglitazone—Immune system disorder—Risedronate—osteoporosis	0.000573	0.00265	CcSEcCtD
Rosiglitazone—Myalgia—Ibandronate—osteoporosis	0.00057	0.00264	CcSEcCtD
Rosiglitazone—Arthralgia—Ibandronate—osteoporosis	0.00057	0.00264	CcSEcCtD
Rosiglitazone—Oedema—Estropipate—osteoporosis	0.00057	0.00264	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Estropipate—osteoporosis	0.00057	0.00264	CcSEcCtD
Rosiglitazone—Infection—Estropipate—osteoporosis	0.000566	0.00262	CcSEcCtD
Rosiglitazone—Malnutrition—Ethinyl Estradiol—osteoporosis	0.000566	0.00262	CcSEcCtD
Rosiglitazone—Hypertension—Calcitriol—osteoporosis	0.000566	0.00262	CcSEcCtD
Rosiglitazone—Constipation—Etidronic acid—osteoporosis	0.000563	0.00261	CcSEcCtD
Rosiglitazone—Eye disorder—Pamidronate—osteoporosis	0.000563	0.00261	CcSEcCtD
Rosiglitazone—Cardiac disorder—Pamidronate—osteoporosis	0.000559	0.00259	CcSEcCtD
Rosiglitazone—Nervous system disorder—Estropipate—osteoporosis	0.000559	0.00259	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Conjugated Estrogens—osteoporosis	0.000558	0.00258	CcSEcCtD
Rosiglitazone—Myalgia—Calcitriol—osteoporosis	0.000558	0.00258	CcSEcCtD
Rosiglitazone—Infection—Alendronate—osteoporosis	0.000558	0.00258	CcSEcCtD
Rosiglitazone—Sinusitis—Conjugated Estrogens—osteoporosis	0.000554	0.00256	CcSEcCtD
Rosiglitazone—Malnutrition—Risedronate—osteoporosis	0.000552	0.00255	CcSEcCtD
Rosiglitazone—Infection—Raloxifene—osteoporosis	0.000549	0.00254	CcSEcCtD
Rosiglitazone—Nasopharyngitis—Estradiol—osteoporosis	0.000548	0.00254	CcSEcCtD
Rosiglitazone—Back pain—Ethinyl Estradiol—osteoporosis	0.000548	0.00253	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Ibandronate—osteoporosis	0.000547	0.00253	CcSEcCtD
Rosiglitazone—Immune system disorder—Pamidronate—osteoporosis	0.000544	0.00252	CcSEcCtD
Rosiglitazone—Infection—Ibandronate—osteoporosis	0.000543	0.00251	CcSEcCtD
Rosiglitazone—Oedema peripheral—Zoledronate—osteoporosis	0.000542	0.00251	CcSEcCtD
Rosiglitazone—Nervous system disorder—Raloxifene—osteoporosis	0.000541	0.0025	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Zoledronate—osteoporosis	0.000541	0.0025	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Raloxifene—osteoporosis	0.000541	0.0025	CcSEcCtD
Rosiglitazone—Nervous system disorder—Ibandronate—osteoporosis	0.000536	0.00248	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Calcitriol—osteoporosis	0.000535	0.00247	CcSEcCtD
Rosiglitazone—Back pain—Risedronate—osteoporosis	0.000534	0.00247	CcSEcCtD
Rosiglitazone—Nausea—Ergocalciferol—osteoporosis	0.000527	0.00244	CcSEcCtD
Rosiglitazone—Malnutrition—Pamidronate—osteoporosis	0.000525	0.00243	CcSEcCtD
Rosiglitazone—Urticaria—Etidronic acid—osteoporosis	0.000523	0.00242	CcSEcCtD
Rosiglitazone—Oedema peripheral—Conjugated Estrogens—osteoporosis	0.000522	0.00242	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Estropipate—osteoporosis	0.000519	0.0024	CcSEcCtD
Rosiglitazone—Angioedema—Ethinyl Estradiol—osteoporosis	0.000517	0.00239	CcSEcCtD
Rosiglitazone—Eye disorder—Zoledronate—osteoporosis	0.000515	0.00238	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Alendronate—osteoporosis	0.000511	0.00237	CcSEcCtD
Rosiglitazone—Cardiac disorder—Zoledronate—osteoporosis	0.000511	0.00236	CcSEcCtD
Rosiglitazone—Anaemia—Risedronate—osteoporosis	0.00051	0.00236	CcSEcCtD
Rosiglitazone—Back pain—Pamidronate—osteoporosis	0.000508	0.00235	CcSEcCtD
Rosiglitazone—Angioedema—Risedronate—osteoporosis	0.000504	0.00233	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.000503	0.00233	CcSEcCtD
Rosiglitazone—Erythema multiforme—Conjugated Estrogens—osteoporosis	0.000501	0.00232	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.000498	0.0023	CcSEcCtD
Rosiglitazone—Immune system disorder—Zoledronate—osteoporosis	0.000497	0.0023	CcSEcCtD
Rosiglitazone—Eye disorder—Conjugated Estrogens—osteoporosis	0.000495	0.00229	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Estradiol—osteoporosis	0.000493	0.00228	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Estropipate—osteoporosis	0.000492	0.00228	CcSEcCtD
Rosiglitazone—Cardiac disorder—Conjugated Estrogens—osteoporosis	0.000492	0.00228	CcSEcCtD
Rosiglitazone—Fatigue—Estropipate—osteoporosis	0.000491	0.00227	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.000487	0.00225	CcSEcCtD
Rosiglitazone—Constipation—Estropipate—osteoporosis	0.000487	0.00225	CcSEcCtD
Rosiglitazone—Anaemia—Pamidronate—osteoporosis	0.000485	0.00224	CcSEcCtD
Rosiglitazone—Weight increased—Estradiol—osteoporosis	0.000482	0.00223	CcSEcCtD
Rosiglitazone—Constipation—Alendronate—osteoporosis	0.00048	0.00222	CcSEcCtD
Rosiglitazone—Angioedema—Pamidronate—osteoporosis	0.000479	0.00222	CcSEcCtD
Rosiglitazone—Malnutrition—Zoledronate—osteoporosis	0.000479	0.00222	CcSEcCtD
Rosiglitazone—Immune system disorder—Conjugated Estrogens—osteoporosis	0.000479	0.00221	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Estradiol—osteoporosis	0.000478	0.00221	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000477	0.0022	CcSEcCtD
Rosiglitazone—Hypertension—Risedronate—osteoporosis	0.000477	0.0022	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000472	0.00218	CcSEcCtD
Rosiglitazone—Fatigue—Ibandronate—osteoporosis	0.000471	0.00218	CcSEcCtD
Rosiglitazone—Myalgia—Risedronate—osteoporosis	0.00047	0.00217	CcSEcCtD
Rosiglitazone—Arthralgia—Risedronate—osteoporosis	0.00047	0.00217	CcSEcCtD
Rosiglitazone—Leukopenia—Pamidronate—osteoporosis	0.00047	0.00217	CcSEcCtD
Rosiglitazone—Constipation—Ibandronate—osteoporosis	0.000467	0.00216	CcSEcCtD
Rosiglitazone—Pruritus—Etidronic acid—osteoporosis	0.000466	0.00216	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Estradiol—osteoporosis	0.000466	0.00215	CcSEcCtD
Rosiglitazone—Back pain—Zoledronate—osteoporosis	0.000464	0.00214	CcSEcCtD
Rosiglitazone—Myocardial infarction—Estradiol—osteoporosis	0.000463	0.00214	CcSEcCtD
Rosiglitazone—Oedema—Ethinyl Estradiol—osteoporosis	0.000462	0.00214	CcSEcCtD
Rosiglitazone—Malnutrition—Conjugated Estrogens—osteoporosis	0.000461	0.00213	CcSEcCtD
Rosiglitazone—Infection—Ethinyl Estradiol—osteoporosis	0.000459	0.00212	CcSEcCtD
Rosiglitazone—Constipation—Calcitriol—osteoporosis	0.000458	0.00212	CcSEcCtD
Rosiglitazone—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000453	0.0021	CcSEcCtD
Rosiglitazone—Hypertension—Pamidronate—osteoporosis	0.000453	0.0021	CcSEcCtD
Rosiglitazone—Urticaria—Estropipate—osteoporosis	0.000453	0.00209	CcSEcCtD
Rosiglitazone—Diarrhoea—Etidronic acid—osteoporosis	0.000451	0.00209	CcSEcCtD
Rosiglitazone—Infection—Risedronate—osteoporosis	0.000448	0.00207	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Estradiol—osteoporosis	0.000447	0.00207	CcSEcCtD
Rosiglitazone—Arthralgia—Pamidronate—osteoporosis	0.000447	0.00207	CcSEcCtD
Rosiglitazone—Myalgia—Pamidronate—osteoporosis	0.000447	0.00207	CcSEcCtD
Rosiglitazone—Back pain—Conjugated Estrogens—osteoporosis	0.000446	0.00206	CcSEcCtD
Rosiglitazone—Urticaria—Alendronate—osteoporosis	0.000446	0.00206	CcSEcCtD
Rosiglitazone—Sinusitis—Estradiol—osteoporosis	0.000443	0.00205	CcSEcCtD
Rosiglitazone—Anaemia—Zoledronate—osteoporosis	0.000443	0.00205	CcSEcCtD
Rosiglitazone—Nervous system disorder—Risedronate—osteoporosis	0.000442	0.00204	CcSEcCtD
Rosiglitazone—Angioedema—Zoledronate—osteoporosis	0.000438	0.00203	CcSEcCtD
Rosiglitazone—Urticaria—Ibandronate—osteoporosis	0.000434	0.00201	CcSEcCtD
Rosiglitazone—Leukopenia—Zoledronate—osteoporosis	0.000429	0.00198	CcSEcCtD
Rosiglitazone—Oedema—Pamidronate—osteoporosis	0.000428	0.00198	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Pamidronate—osteoporosis	0.000428	0.00198	CcSEcCtD
Rosiglitazone—Infection—Pamidronate—osteoporosis	0.000425	0.00197	CcSEcCtD
Rosiglitazone—Urticaria—Calcitriol—osteoporosis	0.000425	0.00197	CcSEcCtD
Rosiglitazone—Hepatitis—Estradiol—osteoporosis	0.000424	0.00196	CcSEcCtD
Rosiglitazone—Angioedema—Conjugated Estrogens—osteoporosis	0.000422	0.00195	CcSEcCtD
Rosiglitazone—Nervous system disorder—Pamidronate—osteoporosis	0.00042	0.00194	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Pamidronate—osteoporosis	0.000419	0.00194	CcSEcCtD
Rosiglitazone—Oedema peripheral—Estradiol—osteoporosis	0.000418	0.00193	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Estradiol—osteoporosis	0.000417	0.00193	CcSEcCtD
Rosiglitazone—Rash—Etidronic acid—osteoporosis	0.000415	0.00192	CcSEcCtD
Rosiglitazone—Dermatitis—Etidronic acid—osteoporosis	0.000415	0.00192	CcSEcCtD
Rosiglitazone—Hypertension—Zoledronate—osteoporosis	0.000414	0.00191	CcSEcCtD
Rosiglitazone—Headache—Etidronic acid—osteoporosis	0.000413	0.00191	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Risedronate—osteoporosis	0.00041	0.0019	CcSEcCtD
Rosiglitazone—Asthenia—Estropipate—osteoporosis	0.000409	0.00189	CcSEcCtD
Rosiglitazone—Myalgia—Zoledronate—osteoporosis	0.000408	0.00189	CcSEcCtD
Rosiglitazone—Arthralgia—Zoledronate—osteoporosis	0.000408	0.00189	CcSEcCtD
Rosiglitazone—Pruritus—Estropipate—osteoporosis	0.000403	0.00187	CcSEcCtD
Rosiglitazone—Asthenia—Alendronate—osteoporosis	0.000403	0.00186	CcSEcCtD
Rosiglitazone—Erythema multiforme—Estradiol—osteoporosis	0.000401	0.00186	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000399	0.00184	CcSEcCtD
Rosiglitazone—Fatigue—Ethinyl Estradiol—osteoporosis	0.000398	0.00184	CcSEcCtD
Rosiglitazone—Pruritus—Alendronate—osteoporosis	0.000397	0.00184	CcSEcCtD
Rosiglitazone—Eye disorder—Estradiol—osteoporosis	0.000396	0.00183	CcSEcCtD
Rosiglitazone—Constipation—Ethinyl Estradiol—osteoporosis	0.000395	0.00183	CcSEcCtD
Rosiglitazone—Cardiac disorder—Estradiol—osteoporosis	0.000394	0.00182	CcSEcCtD
Rosiglitazone—Myalgia—Conjugated Estrogens—osteoporosis	0.000393	0.00182	CcSEcCtD
Rosiglitazone—Arthralgia—Conjugated Estrogens—osteoporosis	0.000393	0.00182	CcSEcCtD
Rosiglitazone—Asthenia—Ibandronate—osteoporosis	0.000392	0.00181	CcSEcCtD
Rosiglitazone—Nausea—Etidronic acid—osteoporosis	0.000391	0.00181	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Zoledronate—osteoporosis	0.000391	0.00181	CcSEcCtD
Rosiglitazone—Oedema—Zoledronate—osteoporosis	0.000391	0.00181	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.00039	0.0018	CcSEcCtD
Rosiglitazone—Diarrhoea—Estropipate—osteoporosis	0.00039	0.0018	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Risedronate—osteoporosis	0.000389	0.0018	CcSEcCtD
Rosiglitazone—Infection—Zoledronate—osteoporosis	0.000389	0.0018	CcSEcCtD
Rosiglitazone—Fatigue—Risedronate—osteoporosis	0.000388	0.0018	CcSEcCtD
Rosiglitazone—Pruritus—Ibandronate—osteoporosis	0.000387	0.00179	CcSEcCtD
Rosiglitazone—Constipation—Risedronate—osteoporosis	0.000385	0.00178	CcSEcCtD
Rosiglitazone—Diarrhoea—Alendronate—osteoporosis	0.000384	0.00178	CcSEcCtD
Rosiglitazone—Asthenia—Calcitriol—osteoporosis	0.000384	0.00178	CcSEcCtD
Rosiglitazone—Nervous system disorder—Zoledronate—osteoporosis	0.000384	0.00177	CcSEcCtD
Rosiglitazone—Immune system disorder—Estradiol—osteoporosis	0.000383	0.00177	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Zoledronate—osteoporosis	0.000383	0.00177	CcSEcCtD
Rosiglitazone—Pruritus—Calcitriol—osteoporosis	0.000379	0.00175	CcSEcCtD
Rosiglitazone—Diarrhoea—Raloxifene—osteoporosis	0.000378	0.00175	CcSEcCtD
Rosiglitazone—Dizziness—Estropipate—osteoporosis	0.000377	0.00174	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000377	0.00174	CcSEcCtD
Rosiglitazone—Oedema—Conjugated Estrogens—osteoporosis	0.000377	0.00174	CcSEcCtD
Rosiglitazone—Infection—Conjugated Estrogens—osteoporosis	0.000374	0.00173	CcSEcCtD
Rosiglitazone—Diarrhoea—Ibandronate—osteoporosis	0.000374	0.00173	CcSEcCtD
Rosiglitazone—Dizziness—Alendronate—osteoporosis	0.000371	0.00172	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00037	0.00171	CcSEcCtD
Rosiglitazone—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000369	0.00171	CcSEcCtD
Rosiglitazone—Malnutrition—Estradiol—osteoporosis	0.000369	0.00171	CcSEcCtD
Rosiglitazone—Fatigue—Pamidronate—osteoporosis	0.000369	0.00171	CcSEcCtD
Rosiglitazone—Urticaria—Ethinyl Estradiol—osteoporosis	0.000367	0.0017	CcSEcCtD
Rosiglitazone—Constipation—Pamidronate—osteoporosis	0.000366	0.00169	CcSEcCtD
Rosiglitazone—Diarrhoea—Calcitriol—osteoporosis	0.000366	0.00169	CcSEcCtD
Rosiglitazone—Dizziness—Raloxifene—osteoporosis	0.000365	0.00169	CcSEcCtD
Rosiglitazone—Dizziness—Ibandronate—osteoporosis	0.000361	0.00167	CcSEcCtD
Rosiglitazone—Rash—Estropipate—osteoporosis	0.000359	0.00166	CcSEcCtD
Rosiglitazone—Dermatitis—Estropipate—osteoporosis	0.000359	0.00166	CcSEcCtD
Rosiglitazone—Urticaria—Risedronate—osteoporosis	0.000358	0.00166	CcSEcCtD
Rosiglitazone—Back pain—Estradiol—osteoporosis	0.000357	0.00165	CcSEcCtD
Rosiglitazone—Headache—Estropipate—osteoporosis	0.000357	0.00165	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000356	0.00165	CcSEcCtD
Rosiglitazone—Rash—Alendronate—osteoporosis	0.000354	0.00164	CcSEcCtD
Rosiglitazone—Dermatitis—Alendronate—osteoporosis	0.000354	0.00164	CcSEcCtD
Rosiglitazone—Headache—Alendronate—osteoporosis	0.000352	0.00163	CcSEcCtD
Rosiglitazone—Rash—Raloxifene—osteoporosis	0.000348	0.00161	CcSEcCtD
Rosiglitazone—Dermatitis—Raloxifene—osteoporosis	0.000348	0.00161	CcSEcCtD
Rosiglitazone—Headache—Raloxifene—osteoporosis	0.000346	0.0016	CcSEcCtD
Rosiglitazone—Rash—Ibandronate—osteoporosis	0.000345	0.00159	CcSEcCtD
Rosiglitazone—Dermatitis—Ibandronate—osteoporosis	0.000344	0.00159	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000343	0.00159	CcSEcCtD
Rosiglitazone—Headache—Ibandronate—osteoporosis	0.000342	0.00158	CcSEcCtD
Rosiglitazone—Nausea—Estropipate—osteoporosis	0.000339	0.00157	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000338	0.00156	CcSEcCtD
Rosiglitazone—Angioedema—Estradiol—osteoporosis	0.000337	0.00156	CcSEcCtD
Rosiglitazone—Rash—Calcitriol—osteoporosis	0.000337	0.00156	CcSEcCtD
Rosiglitazone—Fatigue—Zoledronate—osteoporosis	0.000337	0.00156	CcSEcCtD
Rosiglitazone—Dermatitis—Calcitriol—osteoporosis	0.000337	0.00156	CcSEcCtD
Rosiglitazone—Headache—Calcitriol—osteoporosis	0.000335	0.00155	CcSEcCtD
Rosiglitazone—Constipation—Zoledronate—osteoporosis	0.000334	0.00155	CcSEcCtD
Rosiglitazone—Nausea—Alendronate—osteoporosis	0.000333	0.00154	CcSEcCtD
Rosiglitazone—Asthenia—Ethinyl Estradiol—osteoporosis	0.000331	0.00153	CcSEcCtD
Rosiglitazone—Nausea—Raloxifene—osteoporosis	0.000328	0.00152	CcSEcCtD
Rosiglitazone—Pruritus—Ethinyl Estradiol—osteoporosis	0.000327	0.00151	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000325	0.0015	CcSEcCtD
Rosiglitazone—Fatigue—Conjugated Estrogens—osteoporosis	0.000325	0.0015	CcSEcCtD
Rosiglitazone—Nausea—Ibandronate—osteoporosis	0.000325	0.0015	CcSEcCtD
Rosiglitazone—Asthenia—Risedronate—osteoporosis	0.000323	0.00149	CcSEcCtD
Rosiglitazone—Constipation—Conjugated Estrogens—osteoporosis	0.000322	0.00149	CcSEcCtD
Rosiglitazone—Hypertension—Estradiol—osteoporosis	0.000319	0.00147	CcSEcCtD
Rosiglitazone—Pruritus—Risedronate—osteoporosis	0.000319	0.00147	CcSEcCtD
Rosiglitazone—Nausea—Calcitriol—osteoporosis	0.000318	0.00147	CcSEcCtD
Rosiglitazone—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000316	0.00146	CcSEcCtD
Rosiglitazone—Arthralgia—Estradiol—osteoporosis	0.000314	0.00145	CcSEcCtD
Rosiglitazone—Myalgia—Estradiol—osteoporosis	0.000314	0.00145	CcSEcCtD
Rosiglitazone—Urticaria—Zoledronate—osteoporosis	0.000311	0.00144	CcSEcCtD
Rosiglitazone—Diarrhoea—Risedronate—osteoporosis	0.000308	0.00143	CcSEcCtD
Rosiglitazone—Asthenia—Pamidronate—osteoporosis	0.000307	0.00142	CcSEcCtD
Rosiglitazone—Dizziness—Ethinyl Estradiol—osteoporosis	0.000306	0.00141	CcSEcCtD
Rosiglitazone—Pruritus—Pamidronate—osteoporosis	0.000303	0.0014	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Estradiol—osteoporosis	0.000301	0.00139	CcSEcCtD
Rosiglitazone—Oedema—Estradiol—osteoporosis	0.000301	0.00139	CcSEcCtD
Rosiglitazone—Infection—Estradiol—osteoporosis	0.000299	0.00139	CcSEcCtD
Rosiglitazone—Urticaria—Conjugated Estrogens—osteoporosis	0.000299	0.00138	CcSEcCtD
Rosiglitazone—Dizziness—Risedronate—osteoporosis	0.000298	0.00138	CcSEcCtD
Rosiglitazone—Nervous system disorder—Estradiol—osteoporosis	0.000296	0.00137	CcSEcCtD
Rosiglitazone—Diarrhoea—Pamidronate—osteoporosis	0.000293	0.00136	CcSEcCtD
Rosiglitazone—Rash—Ethinyl Estradiol—osteoporosis	0.000291	0.00135	CcSEcCtD
Rosiglitazone—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000291	0.00135	CcSEcCtD
Rosiglitazone—Headache—Ethinyl Estradiol—osteoporosis	0.000289	0.00134	CcSEcCtD
Rosiglitazone—Rash—Risedronate—osteoporosis	0.000284	0.00131	CcSEcCtD
Rosiglitazone—Dermatitis—Risedronate—osteoporosis	0.000284	0.00131	CcSEcCtD
Rosiglitazone—Dizziness—Pamidronate—osteoporosis	0.000283	0.00131	CcSEcCtD
Rosiglitazone—Headache—Risedronate—osteoporosis	0.000282	0.00131	CcSEcCtD
Rosiglitazone—Asthenia—Zoledronate—osteoporosis	0.000281	0.0013	CcSEcCtD
Rosiglitazone—Pruritus—Zoledronate—osteoporosis	0.000277	0.00128	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000275	0.00127	CcSEcCtD
Rosiglitazone—Nausea—Ethinyl Estradiol—osteoporosis	0.000274	0.00127	CcSEcCtD
Rosiglitazone—Asthenia—Conjugated Estrogens—osteoporosis	0.00027	0.00125	CcSEcCtD
Rosiglitazone—Rash—Pamidronate—osteoporosis	0.00027	0.00125	CcSEcCtD
Rosiglitazone—Dermatitis—Pamidronate—osteoporosis	0.00027	0.00125	CcSEcCtD
Rosiglitazone—Headache—Pamidronate—osteoporosis	0.000268	0.00124	CcSEcCtD
Rosiglitazone—Diarrhoea—Zoledronate—osteoporosis	0.000268	0.00124	CcSEcCtD
Rosiglitazone—Nausea—Risedronate—osteoporosis	0.000268	0.00124	CcSEcCtD
Rosiglitazone—Pruritus—Conjugated Estrogens—osteoporosis	0.000266	0.00123	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Estradiol—osteoporosis	0.00026	0.0012	CcSEcCtD
Rosiglitazone—Fatigue—Estradiol—osteoporosis	0.00026	0.0012	CcSEcCtD
Rosiglitazone—Dizziness—Zoledronate—osteoporosis	0.000259	0.0012	CcSEcCtD
Rosiglitazone—Constipation—Estradiol—osteoporosis	0.000258	0.00119	CcSEcCtD
Rosiglitazone—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000258	0.00119	CcSEcCtD
Rosiglitazone—Nausea—Pamidronate—osteoporosis	0.000254	0.00118	CcSEcCtD
Rosiglitazone—Dizziness—Conjugated Estrogens—osteoporosis	0.000249	0.00115	CcSEcCtD
Rosiglitazone—Rash—Zoledronate—osteoporosis	0.000247	0.00114	CcSEcCtD
Rosiglitazone—Dermatitis—Zoledronate—osteoporosis	0.000246	0.00114	CcSEcCtD
Rosiglitazone—Headache—Zoledronate—osteoporosis	0.000245	0.00113	CcSEcCtD
Rosiglitazone—Urticaria—Estradiol—osteoporosis	0.000239	0.00111	CcSEcCtD
Rosiglitazone—Rash—Conjugated Estrogens—osteoporosis	0.000237	0.0011	CcSEcCtD
Rosiglitazone—Dermatitis—Conjugated Estrogens—osteoporosis	0.000237	0.0011	CcSEcCtD
Rosiglitazone—Headache—Conjugated Estrogens—osteoporosis	0.000236	0.00109	CcSEcCtD
Rosiglitazone—Nausea—Zoledronate—osteoporosis	0.000232	0.00107	CcSEcCtD
Rosiglitazone—Nausea—Conjugated Estrogens—osteoporosis	0.000224	0.00103	CcSEcCtD
Rosiglitazone—Asthenia—Estradiol—osteoporosis	0.000216	0.001	CcSEcCtD
Rosiglitazone—Pruritus—Estradiol—osteoporosis	0.000213	0.000986	CcSEcCtD
Rosiglitazone—Diarrhoea—Estradiol—osteoporosis	0.000206	0.000954	CcSEcCtD
Rosiglitazone—Dizziness—Estradiol—osteoporosis	0.000199	0.000922	CcSEcCtD
Rosiglitazone—Rash—Estradiol—osteoporosis	0.00019	0.000879	CcSEcCtD
Rosiglitazone—Dermatitis—Estradiol—osteoporosis	0.00019	0.000878	CcSEcCtD
Rosiglitazone—Headache—Estradiol—osteoporosis	0.000189	0.000873	CcSEcCtD
Rosiglitazone—Nausea—Estradiol—osteoporosis	0.000179	0.000828	CcSEcCtD
Rosiglitazone—CYP2A6—Metabolism—MGLL—osteoporosis	5.19e-05	0.000523	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	5.18e-05	0.000522	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	5.18e-05	0.000522	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—FGA—osteoporosis	5.13e-05	0.000517	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—RAP1A—osteoporosis	5.09e-05	0.000513	CbGpPWpGaD
Rosiglitazone—CYP2A6—NRF2 pathway—TGFB1—osteoporosis	5.04e-05	0.000508	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—FDPS—osteoporosis	4.94e-05	0.000497	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PKM—osteoporosis	4.94e-05	0.000497	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—CYP27A1—osteoporosis	4.94e-05	0.000497	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PKM—osteoporosis	4.91e-05	0.000495	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—FDPS—osteoporosis	4.91e-05	0.000495	CbGpPWpGaD
Rosiglitazone—ALB—Folate Metabolism—IL6—osteoporosis	4.87e-05	0.00049	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—IL6R—osteoporosis	4.85e-05	0.000489	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.83e-05	0.000487	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—ACP5—osteoporosis	4.8e-05	0.000484	CbGpPWpGaD
Rosiglitazone—ALB—Selenium Micronutrient Network—TNF—osteoporosis	4.79e-05	0.000483	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.74e-05	0.000478	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GPD2—osteoporosis	4.68e-05	0.000472	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PGLS—osteoporosis	4.68e-05	0.000472	CbGpPWpGaD
Rosiglitazone—CYP2C19—Biological oxidations—POMC—osteoporosis	4.67e-05	0.000471	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—IDH2—osteoporosis	4.67e-05	0.00047	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—FGB—osteoporosis	4.66e-05	0.00047	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—ESR2—osteoporosis	4.66e-05	0.00047	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GPD2—osteoporosis	4.65e-05	0.000469	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PGLS—osteoporosis	4.65e-05	0.000469	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.52e-05	0.000456	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—TPI1—osteoporosis	4.46e-05	0.00045	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.44e-05	0.000448	CbGpPWpGaD
Rosiglitazone—PPARG—Circadian rythm related genes—IL6—osteoporosis	4.44e-05	0.000447	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	4.43e-05	0.000446	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—IDH2—osteoporosis	4.42e-05	0.000445	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PKM—osteoporosis	4.41e-05	0.000444	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—FDPS—osteoporosis	4.41e-05	0.000444	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.41e-05	0.000444	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—CYP27A1—osteoporosis	4.39e-05	0.000442	CbGpPWpGaD
Rosiglitazone—CYP2D6—Biological oxidations—POMC—osteoporosis	4.3e-05	0.000433	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PNP—osteoporosis	4.28e-05	0.000431	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ATIC—osteoporosis	4.28e-05	0.000431	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—ACP5—osteoporosis	4.27e-05	0.00043	CbGpPWpGaD
Rosiglitazone—CYP2C9—Biological oxidations—POMC—osteoporosis	4.26e-05	0.000429	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ATIC—osteoporosis	4.26e-05	0.000429	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PNP—osteoporosis	4.26e-05	0.000429	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.22e-05	0.000425	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—P4HB—osteoporosis	4.2e-05	0.000423	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PGLS—osteoporosis	4.18e-05	0.000421	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GPD2—osteoporosis	4.18e-05	0.000421	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—CYP27A1—osteoporosis	4.15e-05	0.000418	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—GAPDH—osteoporosis	4.12e-05	0.000415	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—ENO1—osteoporosis	4.12e-05	0.000415	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—IGF1—osteoporosis	4.1e-05	0.000413	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PSMA5—osteoporosis	4.06e-05	0.000409	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PSMA2—osteoporosis	4.06e-05	0.000409	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—FDPS—osteoporosis	4.05e-05	0.000408	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PKM—osteoporosis	4.05e-05	0.000408	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—ACP5—osteoporosis	4.04e-05	0.000407	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PKM—osteoporosis	4.02e-05	0.000405	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—FDPS—osteoporosis	4.02e-05	0.000405	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—RAP1A—osteoporosis	4.01e-05	0.000404	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—TPI1—osteoporosis	3.97e-05	0.0004	CbGpPWpGaD
Rosiglitazone—ALB—Selenium Micronutrient Network—IL6—osteoporosis	3.87e-05	0.00039	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PGLS—osteoporosis	3.84e-05	0.000387	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GPD2—osteoporosis	3.84e-05	0.000387	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PNP—osteoporosis	3.82e-05	0.000385	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ATIC—osteoporosis	3.82e-05	0.000385	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PGLS—osteoporosis	3.81e-05	0.000384	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GPD2—osteoporosis	3.81e-05	0.000384	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.77e-05	0.000379	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—TPI1—osteoporosis	3.75e-05	0.000378	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—P4HB—osteoporosis	3.73e-05	0.000376	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—VDR—osteoporosis	3.7e-05	0.000373	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—GAPDH—osteoporosis	3.66e-05	0.000369	CbGpPWpGaD
Rosiglitazone—CYP1A2—Biological oxidations—POMC—osteoporosis	3.64e-05	0.000367	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—OXCT1—osteoporosis	3.64e-05	0.000367	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CA2—osteoporosis	3.64e-05	0.000367	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—OXCT1—osteoporosis	3.62e-05	0.000365	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CA2—osteoporosis	3.62e-05	0.000365	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—RAP1A—osteoporosis	3.57e-05	0.00036	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—MGLL—osteoporosis	3.55e-05	0.000357	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—P4HB—osteoporosis	3.53e-05	0.000356	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—MGLL—osteoporosis	3.53e-05	0.000355	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ATIC—osteoporosis	3.51e-05	0.000354	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PNP—osteoporosis	3.51e-05	0.000354	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.5e-05	0.000352	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PNP—osteoporosis	3.48e-05	0.000351	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ATIC—osteoporosis	3.48e-05	0.000351	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—GAPDH—osteoporosis	3.47e-05	0.000349	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—FDPS—osteoporosis	3.43e-05	0.000346	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PKM—osteoporosis	3.43e-05	0.000346	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—RAP1A—osteoporosis	3.38e-05	0.00034	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.35e-05	0.000337	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.33e-05	0.000335	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—CYP19A1—osteoporosis	3.29e-05	0.000332	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PGLS—osteoporosis	3.26e-05	0.000328	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GPD2—osteoporosis	3.26e-05	0.000328	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CA2—osteoporosis	3.25e-05	0.000327	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—OXCT1—osteoporosis	3.25e-05	0.000327	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—ENO1—osteoporosis	3.24e-05	0.000327	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PSMA2—osteoporosis	3.2e-05	0.000322	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PSMA5—osteoporosis	3.2e-05	0.000322	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—MGLL—osteoporosis	3.17e-05	0.000319	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.11e-05	0.000314	CbGpPWpGaD
Rosiglitazone—PPARG—Generic Transcription Pathway—MYC—osteoporosis	3.06e-05	0.000308	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—IDH2—osteoporosis	3.02e-05	0.000304	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—IDH2—osteoporosis	3e-05	0.000302	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—OXCT1—osteoporosis	2.99e-05	0.000301	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CA2—osteoporosis	2.99e-05	0.000301	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.99e-05	0.000301	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PNP—osteoporosis	2.98e-05	0.0003	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ATIC—osteoporosis	2.98e-05	0.0003	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—OXCT1—osteoporosis	2.96e-05	0.000298	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CA2—osteoporosis	2.96e-05	0.000298	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—MGLL—osteoporosis	2.91e-05	0.000293	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—MGLL—osteoporosis	2.89e-05	0.000291	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—ENO1—osteoporosis	2.89e-05	0.000291	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—TGFB1—osteoporosis	2.87e-05	0.000289	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PSMA2—osteoporosis	2.84e-05	0.000286	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PSMA5—osteoporosis	2.84e-05	0.000286	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CYP27A1—osteoporosis	2.84e-05	0.000286	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—ESR1—osteoporosis	2.83e-05	0.000285	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CYP27A1—osteoporosis	2.82e-05	0.000284	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ACP5—osteoporosis	2.76e-05	0.000278	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ACP5—osteoporosis	2.74e-05	0.000276	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—ENO1—osteoporosis	2.73e-05	0.000275	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.72e-05	0.000274	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.72e-05	0.000274	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.71e-05	0.000273	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—IDH2—osteoporosis	2.69e-05	0.000271	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—ADCY5—osteoporosis	2.69e-05	0.000271	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PSMA2—osteoporosis	2.69e-05	0.000271	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PSMA5—osteoporosis	2.69e-05	0.000271	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—GPX1—osteoporosis	2.68e-05	0.00027	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—TNF—osteoporosis	2.68e-05	0.00027	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—CYP19A1—osteoporosis	2.59e-05	0.000261	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.58e-05	0.00026	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—TPI1—osteoporosis	2.56e-05	0.000258	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—TPI1—osteoporosis	2.55e-05	0.000257	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CA2—osteoporosis	2.53e-05	0.000255	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—OXCT1—osteoporosis	2.53e-05	0.000255	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CYP27A1—osteoporosis	2.53e-05	0.000255	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—IDH2—osteoporosis	2.48e-05	0.000249	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—MTHFR—osteoporosis	2.47e-05	0.000249	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—MGLL—osteoporosis	2.47e-05	0.000249	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ACP5—osteoporosis	2.46e-05	0.000248	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	2.46e-05	0.000247	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—IDH2—osteoporosis	2.46e-05	0.000247	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.43e-05	0.000245	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—P4HB—osteoporosis	2.41e-05	0.000243	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—P4HB—osteoporosis	2.4e-05	0.000242	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GAPDH—osteoporosis	2.37e-05	0.000238	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GAPDH—osteoporosis	2.35e-05	0.000237	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CYP27A1—osteoporosis	2.33e-05	0.000235	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.33e-05	0.000234	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CYP27A1—osteoporosis	2.31e-05	0.000233	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—CYP19A1—osteoporosis	2.31e-05	0.000232	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—RAP1A—osteoporosis	2.31e-05	0.000232	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—RAP1A—osteoporosis	2.29e-05	0.000231	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—TPI1—osteoporosis	2.29e-05	0.000231	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ACP5—osteoporosis	2.26e-05	0.000228	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ACP5—osteoporosis	2.25e-05	0.000226	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.22e-05	0.000223	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—CYP19A1—osteoporosis	2.18e-05	0.00022	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—IL6—osteoporosis	2.16e-05	0.000218	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—P4HB—osteoporosis	2.15e-05	0.000217	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—ADCY5—osteoporosis	2.12e-05	0.000213	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GAPDH—osteoporosis	2.11e-05	0.000213	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—IGF1—osteoporosis	2.11e-05	0.000213	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—GPX1—osteoporosis	2.11e-05	0.000213	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—TPI1—osteoporosis	2.11e-05	0.000212	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—IDH2—osteoporosis	2.1e-05	0.000211	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—TPI1—osteoporosis	2.09e-05	0.00021	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—RAP1A—osteoporosis	2.06e-05	0.000207	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.01e-05	0.000203	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2e-05	0.000201	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—P4HB—osteoporosis	1.98e-05	0.000199	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—POMC—osteoporosis	1.98e-05	0.000199	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CYP27A1—osteoporosis	1.97e-05	0.000199	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—P4HB—osteoporosis	1.96e-05	0.000198	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—MTHFR—osteoporosis	1.95e-05	0.000196	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GAPDH—osteoporosis	1.94e-05	0.000196	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GAPDH—osteoporosis	1.93e-05	0.000194	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ACP5—osteoporosis	1.92e-05	0.000193	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.89e-05	0.000191	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—RAP1A—osteoporosis	1.89e-05	0.000191	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—ADCY5—osteoporosis	1.88e-05	0.00019	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—GPX1—osteoporosis	1.88e-05	0.000189	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—RAP1A—osteoporosis	1.88e-05	0.000189	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ENO1—osteoporosis	1.86e-05	0.000188	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ENO1—osteoporosis	1.85e-05	0.000187	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PSMA2—osteoporosis	1.84e-05	0.000185	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PSMA5—osteoporosis	1.84e-05	0.000185	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PSMA2—osteoporosis	1.83e-05	0.000184	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PSMA5—osteoporosis	1.83e-05	0.000184	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.79e-05	0.000181	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—TPI1—osteoporosis	1.78e-05	0.00018	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—ADCY5—osteoporosis	1.78e-05	0.00018	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—GPX1—osteoporosis	1.78e-05	0.000179	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—MTHFR—osteoporosis	1.73e-05	0.000175	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—P4HB—osteoporosis	1.68e-05	0.000169	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ENO1—osteoporosis	1.66e-05	0.000168	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GAPDH—osteoporosis	1.65e-05	0.000166	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PSMA2—osteoporosis	1.64e-05	0.000165	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PSMA5—osteoporosis	1.64e-05	0.000165	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—MTHFR—osteoporosis	1.64e-05	0.000165	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.64e-05	0.000165	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—RAP1A—osteoporosis	1.6e-05	0.000162	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—POMC—osteoporosis	1.56e-05	0.000157	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ENO1—osteoporosis	1.53e-05	0.000154	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ENO1—osteoporosis	1.52e-05	0.000153	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PSMA2—osteoporosis	1.51e-05	0.000152	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PSMA5—osteoporosis	1.51e-05	0.000152	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PSMA5—osteoporosis	1.49e-05	0.000151	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PSMA2—osteoporosis	1.49e-05	0.000151	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CYP19A1—osteoporosis	1.49e-05	0.00015	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CYP19A1—osteoporosis	1.48e-05	0.000149	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—MYC—osteoporosis	1.47e-05	0.000148	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.4e-05	0.000141	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—POMC—osteoporosis	1.39e-05	0.00014	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CYP19A1—osteoporosis	1.33e-05	0.000134	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—POMC—osteoporosis	1.31e-05	0.000132	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ENO1—osteoporosis	1.3e-05	0.000131	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PSMA2—osteoporosis	1.28e-05	0.000129	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PSMA5—osteoporosis	1.28e-05	0.000129	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—TGFB1—osteoporosis	1.27e-05	0.000128	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CYP19A1—osteoporosis	1.22e-05	0.000123	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ADCY5—osteoporosis	1.22e-05	0.000123	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GPX1—osteoporosis	1.21e-05	0.000122	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CYP19A1—osteoporosis	1.21e-05	0.000122	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ADCY5—osteoporosis	1.21e-05	0.000122	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GPX1—osteoporosis	1.21e-05	0.000122	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—MTHFR—osteoporosis	1.12e-05	0.000113	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—MTHFR—osteoporosis	1.11e-05	0.000112	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ADCY5—osteoporosis	1.09e-05	0.000109	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GPX1—osteoporosis	1.08e-05	0.000109	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CYP19A1—osteoporosis	1.04e-05	0.000104	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ADCY5—osteoporosis	9.99e-06	0.000101	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—MTHFR—osteoporosis	9.99e-06	0.000101	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GPX1—osteoporosis	9.96e-06	0.0001	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ADCY5—osteoporosis	9.91e-06	9.98e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GPX1—osteoporosis	9.87e-06	9.95e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—MTHFR—osteoporosis	9.19e-06	9.26e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—MTHFR—osteoporosis	9.11e-06	9.18e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—POMC—osteoporosis	8.95e-06	9.02e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—POMC—osteoporosis	8.9e-06	8.97e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ADCY5—osteoporosis	8.47e-06	8.53e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GPX1—osteoporosis	8.44e-06	8.5e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—POMC—osteoporosis	7.99e-06	8.05e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—MTHFR—osteoporosis	7.79e-06	7.84e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—POMC—osteoporosis	7.35e-06	7.4e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—POMC—osteoporosis	7.29e-06	7.34e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—POMC—osteoporosis	6.23e-06	6.27e-05	CbGpPWpGaD
